Events

Verge Genomics Senior Director, Head of Drug Discovery, Irene Choi, will present at the 5th Annual ALS Research Symposium on Friday October 7, 2022.

Verge Genomics Victor Hanson-Smith, Head of Computational Biology, will present on Machine Learning for Accelerating Target Identification: Costs and Benefits at Augmented Intelligence In Drug Discovery XCHANGE.

Verge Genomics Chief Business Officer, Jane Rhodes, PhD, to participate in Fierce Biotech Summit panel: Leverage AI and ML to advance discovery and accelerate drug development.